The evolution of multigene panel testing for hereditary cancers

被引：1
|
作者：
Frieder, Richard E. [1 ]
Snow, Shari Goldman [2 ]
Francis, Marra S. [3 ]
Brodsky, Burton S. [4 ]
机构：
[1] Univ Calif Los Angeles, David Geffen Sch Med, Dept Obstet & Gynecol, Los Angeles, CA 90095 USA
[2] Northwestern Univ, Chicago, IL 60611 USA
[3] Womens Hlth Consultants, San Antonio, TX USA
[4] Wayne State Univ, Sch Med, Detroit, MI USA
来源：
AMERICAN JOURNAL OF OBSTETRICS AND GYNECOLOGY | 2015年 / 212卷 / 01期
关键词：
D O I：
10.1016/j.ajog.2014.08.023
中图分类号：
R71 [妇产科学];
学科分类号：
100211 ;
摘要：
A thorough family history evaluation remains a critical tool that helps identify those patients who are at risk for hereditary cancer. The American College of Obstetricians and Gynecologists (ACOG) recommends that all women receive a family history evaluation to screen for inherited risk, and that this information be regularly updated. Patients with an abnormal cancer family history need additional follow-up that may include hereditary cancer testing. Multigene panel testing provides comprehensive profiling for hereditary cancer patients by identifying more health risks than single genome testing. If hereditary cancer is established, patients should be counseled about management options, including increased surveillance, chemoprevention, and/or surgery. Establishing workflow protocols may help clinicians integrate hereditary cancer risk assessment into their practice. © 2014 Elsevier Inc. All rights reserved.
引用
收藏
页码：123 / 123
页数：1
相关论文
共 50 条
  • [41] The transfer of multigene panel testing for hereditary breast and ovarian cancer to healthcare: What are the implications for the management of patients and families?
    Eliade, Marie
    Skrzypski, Jeremy
    Baurand, Amandine
    Jacquot, Caroline
    Bertolone, Geoffrey
    Loustalot, Catherine
    Coutant, Charles
    Guy, France
    Fumoleau, Pierre
    Duffourd, Yannis
    Arnould, Laurent
    Delignette, Alexandra
    Padeano, Marie-Martine
    Lepage, Come
    Raichon-Patru, Geraldine
    Boudrant, Axelle
    Bone-Lepinoy, Marie-Christine
    Villing, Anne-Laure
    Charpin, Aurelie
    Peignaux, Karine
    Chevrier, Sandy
    Vegran, Frederique
    Ghiringhelli, Francois
    Boidot, Romain
    Sevenet, Nicolas
    Lizard, Sarab
    Faivre, Laurence
    [J]. ONCOTARGET, 2017, 8 (02) : 1957 - 1971
  • [42] Multigene hereditary cancer testing in sarcoma patients.
    Jackson, Sarah A.
    Baxter, Melanie D.
    Mester, Jessica
    Susswein, Lisa
    Marshall, Megan L.
    Hruska, Kathleen S.
    Klein, Rachel T.
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2017, 35
  • [43] Characteristics of ductal carcinoma in situ (DCIS) in patients who underwent multigene panel testing for hereditary breast cancer
    Militello, Loredana
    Barrera, Angelica M. Gutierrez
    Kuerer, Henry
    Albarracin, Constance
    Arun, Banu K.
    [J]. CANCER RESEARCH, 2020, 80 (04)
  • [44] Next-generation sequencing through multigene panel testing for the diagnosis of hereditary epidermolysis bullosa in Chinese population
    Chen, Fuying
    Huang, Linting
    Li, Changcan
    Zhang, Jia
    Yang, Weiqin
    Zhang, Beibei
    Li, Huaguo
    Deng, Dan
    Liang, Jianying
    Shen, Jinwen
    Yao, Zhirong
    Li, Ming
    [J]. CLINICAL GENETICS, 2020, 98 (02) : 179 - 184
  • [45] Clinical Management of Patients at Risk for Hereditary Breast Cancer with Variants of Uncertain Significance in the Era of Multigene Panel Testing
    Jenny Chang
    Sirivan Seng
    June Yoo
    Pamela Equivel
    Sharon S. Lum
    [J]. Annals of Surgical Oncology, 2019, 26 : 3389 - 3396
  • [46] The transfer of multigene panel testing for hereditary breast and ovarian cancer to healthcare: What are the implications for the management of patients and families?
    Lizard, Sarab
    Eliade, Marie
    Skrzypski, Jeremy
    Baurand, Amandine
    Jacquot, Caroline
    Bertolone, Geoffrey
    Loustalot, Catherine
    Coutant, Charles
    Guy, France
    Fumoleau, Pierre
    Duffourd, Yannis
    Arnould, Laurent
    Padeano, Marie-Martine
    Lepage, Come
    Chevrier, Sandy
    Vegran, Frederique
    Sevenet, Nicolas
    Ghiringhelli, Francois
    Boidot, Romain
    Faivre, Laurence
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2016, 34 (15)
  • [47] Application of Multigene Panels Testing for Hereditary Cancer Syndromes
    Bilyalov, Airat
    Nikolaev, Sergey
    Shigapova, Leila
    Khatkov, Igor
    Danishevich, Anastasia
    Zhukova, Ludmila
    Smolin, Sergei
    Titova, Marina
    Lisica, Tatyana
    Bodunova, Natalia
    Shagimardanova, Elena
    Gusev, Oleg
    [J]. BIOLOGY-BASEL, 2022, 11 (10):
  • [48] Multigene Testing for Hereditary Cancer: When, Why, and How
    Offit, Kenneth
    [J]. JOURNAL OF THE NATIONAL COMPREHENSIVE CANCER NETWORK, 2017, 15 (5.5): : 741 - 743
  • [49] Multigene panel testing results for hereditary breast cancer in 1325 individuals: Implications for gene selection and considerations for guidelines
    Tsaousis, G. N.
    Tsoulos, N.
    Papadopoulou, E.
    Agiannitopoulos, K.
    Pepe, G.
    Diamantopoulos, N.
    Floros, T. I.
    Iosifidou, R.
    Markopoulos, C.
    Papazisis, K.
    Venizelos, V.
    Xepapadakis, G.
    Banu, E.
    Eniu, D. T.
    Stanculeanu, D. L.
    Ungureanu, A.
    Tansan, S.
    Tekinel, M.
    Yalcin, S.
    Nasioulas, G.
    [J]. ANNALS OF ONCOLOGY, 2019, 30
  • [50] MULTIGENE PANEL TESTING RESULTS IN PATIENTS WITH DYSLIPIDEMIA.
    Vasiluev, P. A.
    Ivanova, O. N.
    Ezhov, M. V.
    Chubykina, U. V.
    Prus, Y.
    Semenova, N.
    Guseva, D.
    Malyshev, P.
    Zakharova, E.
    Dadali, E.
    [J]. ATHEROSCLEROSIS, 2021, 331 : E214 - E214
12345